18 research outputs found

    A Novel Compound C12 Inhibits Inflammatory Cytokine Production and Protects from Inflammatory Injury In Vivo

    Get PDF
    Inflammation is a hallmark of many diseases. Although steroids and cyclooxygenase inhibitors are main anti-inflammatory therapeutical agents, they may cause serious side effects. Therefore, developing non-steroid anti-inflammatory agents is urgently needed. A novel hydrosoluble compound, C12 (2,6-bis(4-(3-(dimethylamino)-propoxy)benzylidene)cyclohexanone), has been designed and synthesized as an anti-inflammatory agent in our previous study. In the present study, we investigated whether C12 can affect inflammatory processes in vitro and in vivo. In mouse primary peritoneal macrophages, C12 potently inhibited the production of the proinflammatory gene expression including TNF-α, IL-1β, IL-6, iNOS, COX-2 and PGE synthase. The activity of C12 was partly dependent on inhibition of ERK/JNK (but p38) phosphorylation and NF-κB activation. In vivo, C12 suppressed proinflammatory cytokine production in plasma and liver, attenuated lung histopathology, and significantly reduced mortality in endotoxemic mice. In addition, the pre-treatment with C12 reduced the inflammatory pain in the acetic acid and formalin models and reduced the carrageenan-induced paw oedema and acetic acid-increased vascular permeability. Taken together, C12 has multiple anti-inflammatory effects. These findings, coupled with the low toxicity and hydrosolubility of C12, suggests that this agent may be useful in the treatment of inflammatory diseases

    An upper limit to the photon fraction in cosmic rays above 10(19) eV from the Pierre Auger Observatory

    No full text

    An upper limit to the photon fraction in cosmic rays above 10(19) eV from the Pierre Auger Observatory

    No full text

    Operations of and Future Plans for the Pierre Auger Observatory

    No full text
    Contributions to the 31st ICRC, Lodz, Poland, July 2009International audienceTechnical reports on operations and features of the Pierre Auger Observatory, including ongoing and planned enhancements and the status of the future northern hemisphere portion of the Observatory. Contributions to the 31st International Cosmic Ray Conference, Lodz, Poland, July 2009

    Astrophysical Sources of Cosmic Rays and Related Measurements with the Pierre Auger Observatory

    No full text
    Studies of the correlations of ultra-high energy cosmic ray directions with extra-Galactic objects, of general anisotropy, of photons and neutrinos, and of other astrophysical effects, with the Pierre Auger Observatory. Contributions to the 31st ICRC, Lodz, Poland, July 2009

    Studies of Cosmic Ray Composition and Air Shower Structure with the Pierre Auger Observatory

    No full text
    Submissions to the 31st International Cosmic Ray Conference, Lodz, Poland (July 2009)International audienceStudies of the composition of the highest energy cosmic rays with the Pierre Auger Observatory, including examination of hadronic physics effects on the structure of extensive air showers. Submissions to the 31st ICRC, Lodz, Poland (July 2009)

    The Cosmic Ray Energy Spectrum and Related Measurements with the Pierre Auger Observatory

    No full text
    Studies of the cosmic ray energy spectrum at the highest energies with the Pierre Auger Observatory

    Calibration and Monitoring of the Pierre Auger Observatory

    No full text
    Reports on the atmospheric monitoring, calibration, and other operating systems of the Pierre Auger Observatory. Contributions to the 31st International Cosmic Ray Conference, Lodz, Poland, July 2009
    corecore